Ipsos MRBI/IPHA COVID Vaccine Tracker - April 2021

Public appetite for COVID-19 vaccine rises to 85%, says Ipsos MRBI tracker survey for IPHA. Just 6% of people would refuse a COVID-19 vaccine, a consistent trend since the start of the year.

The author(s)

  • Tarik Laher Director
  • Will Nunn Associate Director
Get in touch

The number of people who intend to get vaccinated for COVID-19, or who have already received a vaccine for the disease, has risen to 85%, according to the results of the latest tracker survey by Ipsos MRBI for the Irish Pharmaceutical Healthcare Association (IPHA) which represents the international research-based biopharmaceutical industry. 
   
The results show that 73% of people will take a COVID-19 vaccine. But when combined with the vaccinated cohort, or 12% of the sample*, that number rises to 85% - 10 points higher than the percentage of people who said in January that they would take a COVID-19 vaccine.   

Between January and April, the number of people who said they either won’t get vaccinated for COVID-19 or were unsure about taking a vaccine has declined. In January, 7% said they would refuse a COVID-19 vaccine and 18% were unsure. This month, 6% say they will refuse a COVID-19 vaccine and 10% are unsure. 

Intention to take a COVID-19 vaccine is higher among older age groups and some in these groups have already been vaccinated. While just 6% of people overall say they will not take a COVID-19 vaccine, it is highest among 25 to 34-year-olds, at 10%. While 10% say they are unsure about taking a COVID-19 vaccine, in the 18 to 24-year-old cohort it is 21%. 

 


About The Survey 
Ipsos MRBI conducted 983 telephone interviews with adults aged over 18 between March 31st and April 14th, 2021. The sample was nationally representative for age, gender, geography and social class. 


*The survey may underestimate the number of people who have already received a COVID-19 vaccine because people in nursing homes, hospitals and other care settings were not interviewed.
 

The author(s)

  • Tarik Laher Director
  • Will Nunn Associate Director

More insights about Health